akusherstvoObstetrics, Gynecology and ReproductionАкушерство, Гинекология и Репродукция2313-73472500-3194IRBIS LLC10.17749/2313-7347/ob.gyn.rep.2024.544akusherstvo-2168Research ArticleFROM HISTORYИЗ ИСТОРИИ100 years of Moschcowitz disease and thrombotic microangiopathy research: a look into the past and prospects100 лет исследования болезни Мошковица и тромботической микроангиопатии: взгляд в прошлое и перспективыhttps://orcid.org/0009-0006-6018-4667ШатилинаА. Ю.ShatilinaA. Yu.

Шатилина Анастасия Юрьевна.

119991 Москва, ул. Трубецкая, д. 8, стр. 2

Anastasia Yu. Shatilina.

8 bldg. 2, Trubetskaya Str., Moscow 119991

shatilina1110@gmail.comhttps://orcid.org/0009-0000-5331-7894ГаджиеваА. Б.HajiyevaA. B.

Гаджиева Айгюн Бахтияр кызы.

AZ1143 Баку, проспект Гусейна Джавида, д. 33

Aygun B. Hajiyeva.

33 Huseyn Javid Avenue, Baku, AZ1143

https://orcid.org/0009-0001-1733-7502ВелихановаЛ. М.ValikhanovaL. M.

Велиханова Лала Мехти.

AZ1143 Баку, проспект Гусейна Джавида, д. 33

Lala M. Valikhanova.

33 Huseyn Javid Avenue, Baku, AZ1143

https://orcid.org/0009-0000-8197-4998МещеряковА. A.MeshcheryakovA. A.

Мещеряков Арсений Александрович.

127006 Москва, Долгоруковская ул., д. 4

Arseniy A. Meshcheryakov.

4 Dolgorukovskaya Str., Moscow 127006

https://orcid.org/0000-0003-0764-4477ГашимоваН. Р.GashimovaN. R.

Гашимова Нилуфар Рамиль кызы.

119991 Москва, ул. Трубецкая, д. 8, стр. 2

Nilufar R. Gashimova - MD.

8 bldg. 2, Trubetskaya Str., Moscow 119991

https://orcid.org/0000-0002-7756-8935ГригорьеваК. Н.GrigorevaK. N.

Григорьева Кристина Николаевна.

119991 Москва, ул. Трубецкая, д. 8, стр. 2

Kristina N. Grigoreva - MD.

8 bldg. 2, Trubetskaya Str., Moscow 119991

https://orcid.org/0000-0002-4509-9281ВоробьевА. В.VorobevA. V.

Воробьев Александр Викторович - к.м.н.

119991 Москва, ул. Трубецкая, д. 8, стр. 2

Scopus Author ID 57191966265; Wos ResearcherID F-8804-2017

Alexander V. Vorobev - MD, PhD.

8 bldg. 2, Trubetskaya Str., Moscow 119991

Scopus Author ID 57191966265; Wos ResearcherID F-8804-2017

ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)РоссияSechenov UniversityRussian FederationБакинский филиал ФГАОУ ВО Первый Московский государственный медицинский университет имени И.М. Сеченова Министерства здравоохранения Российской Федерации (Сеченовский Университет)АзербайджанBaku Branch of Sechenov UniversityAzerbaijanФГБОУ ВО «Российский университет медицины» Министерства здравоохранения Российской ФедерацииРоссияRussian University of Medicine, Health Ministry of Russian FederationRussian Federation202412092024184603611Copyright © Shatilina A.Y., Hajiyeva A.B., Valikhanova L.M., Meshcheryakov A.A., Gashimova N.R., Grigoreva K.N., Vorobev A.V., 20242024Шатилина А.Ю., Гаджиева А.Б., Велиханова Л.М., Мещеряков А.A., Гашимова Н.Р., Григорьева К.Н., Воробьев А.В.Shatilina A.Y., Hajiyeva A.B., Valikhanova L.M., Meshcheryakov A.A., Gashimova N.R., Grigoreva K.N., Vorobev A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.gynecology.su/jour/article/view/2168

In this article we review the history of the thrombotic microangiopathy (TMA) study over the past 100 years. Important events and discoveries made by scientists across the globe are described, which profoundly contributed to understanding TMA etiology, pathogenesis and treatment. The prospects for current TMA investigation especially in obstetric practice are discussed.

В статье рассматривается история изучения тромботической микроангиопатии (ТМА) за последние 100 лет. Описаны важные события и открытия ученых со всего мира, внесших большой вклад в понимание этиологии, патогенеза и лечения ТМА. Рассматриваются перспективы изучения ТМА в настоящее время, особенно в акушерской практике.

тромботическая микроангиопатияТМАтромботическая тромбоцитопеническая пурпурагемолитико-уремический синдромсверхбольшие мультимеры фактора фон ВиллебрандаADAMTS-13Эли МошковицДжон УльтманнЭрик Адольф фон ВиллебрандДжефферсон Д. Апшоуthrombotic microangiopathyТМАthrombotic thrombocytopenic purpurahemolytic uremic syndromeultra-large multimers of von Willebrand factorADAMTS-13Eli MoschcowitzJohn UltmannErik Adolf von WillebrandJefferson D. UpshawReferencesMoschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc. 1924;24:21-4.Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease. Proc NY Pathol Soc. 1924;24:21-4.Singer K., Bornstein F.P., Wile S.A. Thrombotic thrombocytopenic purpura; hemorrhagic diathesis with generalized platelet thromboses. Blood. 1947;2(6):542-54.Singer K., Bornstein F.P., Wile S.A. Thrombotic thrombocytopenic purpura; hemorrhagic diathesis with generalized platelet thromboses. Blood. 1947;2(6):542-54.Amorosi E.L., Ultmann J.E. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore). 1966;45(02):139-60.Amorosi E.L., Ultmann J.E. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine (Baltimore). 1966;45(02):139-60.Von Willebrand E.A. Hereditar pseudohemofili. Finska Lakarsallskapets Handl. 1926;67:7-112. (In Swedish).Von Willebrand E.A. Hereditar pseudohemofili. Finska Lakarsallskapets Handl. 1926;67:7-112. (In Swedish).Thachil J., Lassila R. What can historical literature on von Willebrand disease teach us? Res Pract Thromb Haemost. 2023;7(8):102244. https://doi.org/10.1016/j.rpth.2023.102244.Thachil J., Lassila R. What can historical literature on von Willebrand disease teach us? Res Pract Thromb Haemost. 2023;7(8):102244. https://doi.org/10.1016/j.rpth.2023.102244.Upshaw J.D. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med. 1978;298(24):1350-2.Upshaw J.D. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. N Engl J Med. 1978;298(24):1350-2.Gasser C., Gautier E., Steck A. et al. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955;85(38-39):905-9. (In German).Gasser C., Gautier E., Steck A. et al. Hemolytic-uremic syndrome: bilateral necrosis of the renal cortex in acute acquired hemolytic anemia. Schweiz Med Wochenschr. 1955;85(38-39):905-9. (In German).Gasser C. The hemolytic-uremic syndrome. Ther Umsch. 1968;25(8):433-7. (In German).Gasser C. The hemolytic-uremic syndrome. Ther Umsch. 1968;25(8):433-7. (In German).Karmali M.A., Steele B.T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1(8325):619-20. https://doi.org/10.1016/s0140-6736(83)91795-6.Karmali M.A., Steele B.T., Petric M., Lim C. Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools. Lancet. 1983;1(8325):619-20. https://doi.org/10.1016/s0140-6736(83)91795-6.Moake J.L., Rudy C.K., Troll J.H. et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307(23):1432-5. https://doi.org/10.1056/NEJM198212023072306.Moake J.L., Rudy C.K., Troll J.H. et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med. 1982;307(23):1432-5. https://doi.org/10.1056/NEJM198212023072306.Wagner D.D. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 1993;70(1):105-10.Wagner D.D. The Weibel-Palade body: the storage granule for von Willebrand factor and P-selectin. Thromb Haemost. 1993;70(1):105-10.Arya M., Anvari B., Romo G.M. et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002;99(11):3971-7. https://doi.org/10.1182/blood-2001-11-0060.Arya M., Anvari B., Romo G.M. et al. Ultralarge multimers of von Willebrand factor form spontaneous high-strength bonds with the platelet glycoprotein Ib-IX complex: studies using optical tweezers. Blood. 2002;99(11):3971-7. https://doi.org/10.1182/blood-2001-11-0060.Furlan M., Robles B.L.B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87(10):4223-34.Furlan M., Robles B.L.B. Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis. Blood. 1996;87(10):4223-34.Tsai H.M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87(10):4235-44. https://doi.org/10.1182/blood.v87.10.4235.blood-journal87104235.Tsai H.M. Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion. Blood. 1996;87(10):4235-44. https://doi.org/10.1182/blood.v87.10.4235.blood-journal87104235.Furlan M7., Robles R., Solenthaler M. et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097-103.Furlan M7., Robles R., Solenthaler M. et al. Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura. Blood. 1997;89(9):3097-103.Gerritsen H.E., Robles R., Lammle B., Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98(6):1654-61. https://doi.org/10.1182/blood.v98.6.1654.Gerritsen H.E., Robles R., Lammle B., Furlan M. Partial amino acid sequence of purified von Willebrand factor-cleaving protease. Blood. 2001;98(6):1654-61. https://doi.org/10.1182/blood.v98.6.1654.Soejima K., Mimura N., Hirashima M. et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem. 2001;130(4):475-80. https://doi.org/10.1093/oxfordjournals.jbchem.a003009.Soejima K., Mimura N., Hirashima M. et al. A novel human metalloprotease synthesized in the liver and secreted into the blood: possibly, the von Willebrand factor-cleaving protease? J Biochem. 2001;130(4):475-80. https://doi.org/10.1093/oxfordjournals.jbchem.a003009.Fujikawa K., Suzuki H., McMullen B., Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001;98(6):1662-6. https://doi.org/10.1182/blood.v98.6.1662.Fujikawa K., Suzuki H., McMullen B., Chung D. Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family. Blood. 2001;98(6):1662-6. https://doi.org/10.1182/blood.v98.6.1662.Zheng X., Chung D., Takayama T.K. et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276(44):41059-63. https://doi.org/10.1074/jbc.C100515200.Zheng X., Chung D., Takayama T.K. et al. Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura. J Biol Chem. 2001;276(44):41059-63. https://doi.org/10.1074/jbc.C100515200.Tsai H.M., Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-94. https://doi.org/10.1056/NEJM199811263392203.Tsai H.M., Lian E.C. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med. 1998;339(22):1585-94. https://doi.org/10.1056/NEJM199811263392203.Furlan M., Robles R., Galbusera M. et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339(22):1578-84. https://doi.org/10.1056/NEJM199811263392202.Furlan M., Robles R., Galbusera M. et al. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med. 1998;339(22):1578-84. https://doi.org/10.1056/NEJM199811263392202.Ono T., Mimuro J., Madoiwa S. et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107(2):528-34. https://doi.org/10.1182/blood-2005-03-1087.Ono T., Mimuro J., Madoiwa S. et al. Severe secondary deficiency of von Willebrand factor-cleaving protease (ADAMTS13) in patients with sepsis-induced disseminated intravascular coagulation: its correlation with development of renal failure. Blood. 2006;107(2):528-34. https://doi.org/10.1182/blood-2005-03-1087.Plaimauer B., Zimmermann K., Volkel D. et al. Cloning, expression, and functional characterization of the von Willebrand factor - cleaving protease (ADAMTS13). Blood. 2002;100(10):3626-32. https://doi.org/10.1182/blood-2002-05-1397.Plaimauer B., Zimmermann K., Volkel D. et al. Cloning, expression, and functional characterization of the von Willebrand factor - cleaving protease (ADAMTS13). Blood. 2002;100(10):3626-32. https://doi.org/10.1182/blood-2002-05-1397.Antoine G., Zimmermann K., Plaimauer B.et al. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. Br J Haematol. 2003;120(5):821-4. https://doi.org/10.1046/j.1365-2141.2003.04183.x.Antoine G., Zimmermann K., Plaimauer B.et al. ADAMTS13 gene defects in two brothers with constitutional thrombotic thrombocytopenic purpura and normalization of von Willebrand factor-cleaving protease activity by recombinant human ADAMTS13. Br J Haematol. 2003;120(5):821-4. https://doi.org/10.1046/j.1365-2141.2003.04183.x.Rubinstein M.A., Kagan B.M., MacGillviray M.H. et al. Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions. Ann Intern Med. 1959;51:1409-19. https://doi.org/10.7326/0003-4819-51-6-1409.Rubinstein M.A., Kagan B.M., MacGillviray M.H. et al. Unusual remission in a case of thrombotic thrombocytopenic purpura syndrome following fresh blood exchange transfusions. Ann Intern Med. 1959;51:1409-19. https://doi.org/10.7326/0003-4819-51-6-1409.Shepard K.V., Bukowski R.M. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol. 1987;24(3): 178-93.Shepard K.V., Bukowski R.M. The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusions, and plasma exchange. Semin Hematol. 1987;24(3): 178-93.Rock G.A., Shumak K.H., Buskard N.A. et al.; Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325(6):393-7. https://doi.org/10.1056/NEJM199108083250604.Rock G.A., Shumak K.H., Buskard N.A. et al.; Canadian Apheresis Study Group. Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med. 1991;325(6):393-7. https://doi.org/10.1056/NEJM199108083250604.Bell W.R., Braine H.G., Ness P.M., Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325(6):398-403. https://doi.org/10.1056/NEJM199108083250605.Bell W.R., Braine H.G., Ness P.M., Kickler T.S. Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med. 1991;325(6):398-403. https://doi.org/10.1056/NEJM199108083250605.Miner P.E., Nutt R.L., Thomas M.E. Thrombotic thrombocytopenic purpura occurring in pregnancy. Am J Obstet Gynecol. 1955;70(3):611-7. https://doi.org/10.1016/0002-9378(55)90355-0.Miner P.E., Nutt R.L., Thomas M.E. Thrombotic thrombocytopenic purpura occurring in pregnancy. Am J Obstet Gynecol. 1955;70(3):611-7. https://doi.org/10.1016/0002-9378(55)90355-0.Макацария А.Д., Бицадзе В.О., Акиньшина С.В., Андреева М.Д. Патогенез и профилактика осложнений беременности, обусловленных тромботической микроангиопатией. Вопросы гинекологии, акушерства и перинатологии. 2013;12(6):63-73.Makatsariya A.D., Bitsadze V.O., Akinshina S.V., Andreeva M.D. The pathogenesis and prevention of complications of pregnancy conditioned by thrombotic microangiopathy. [Patogenez i profilaktika oslozhnenij beremennosti, obuslovlennyh tromboticheskoj mikroangiopatiej]. Voprosy ginekologii, akusherstva i perinatologii. 2013;12(6):63-73. (In Russ.).Макацария А.Д., Акиньшина С.В., Бицадзе В.О. Преэклампсия и HELLP-синдром как проявление тромботической микроангиопатии. Акушерство и гинекология. 2014;(4):4-10.Makatsariya A.D., Akinshina S.V., Bitsadze V.O. Preeclampsia and HELLP syndrome as a manifestation of thrombotic microangiopathy. [Preeklampsiya i HELLP-sindrom kak proyavlenie tromboticheskoj mikroangiopatii]. Akusherstvo i ginekologiya. 2014;(4):4-10. (In Russ.).Макацария А.Д., Бицадзе В.О., Хирзоева Д.Х., Акиньшина С.В. Тромботические микроангиопатии в акушерской практике. М.: ГЭОТАР-Медиа, 2017. 304 с.Makatsariya A.D., Bitsadze V.O., Khirzoeva J.Kh., Akinshina S.V. Thrombotic microangiopathies in obstetric practice. [Tromboticheskie mikroangiopatii v akusherskoj praktike]. Moscow: GEOTAR-Media, 2017. 304 p. (In Russ.).Antman K.H., Skarin A.T., Mayer R.J. et al. Microangiopathic hemolytic anemia and cancer: a review. Medicine. 1979;58(5):377-84. https://doi.org/10.1097/00005792-197909000-00004.Antman K.H., Skarin A.T., Mayer R.J. et al. Microangiopathic hemolytic anemia and cancer: a review. Medicine. 1979;58(5):377-84. https://doi.org/10.1097/00005792-197909000-00004.Terrell D.R., Williams L.A., Vesely S.K. et al. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432-6. https://doi.org/10.1111/j.1538-7836.2005.01436.x.Terrell D.R., Williams L.A., Vesely S.K. et al. The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency. J Thromb Haemost. 2005;3(7):1432-6. https://doi.org/10.1111/j.1538-7836.2005.01436.x.Макацария А.Д., Элалами И., Воробьев А.В. и др. Тромботическая микроангиопатия у онкологических больных. Вестник РАМН. 2019;74(5):323-32. https://doi.org/10.15690/vramn1204.Makatsariya A.D., Elalami I., Vorobev A.V. et al. Thrombotic microangiopathy in cancer patients. [Tromboticheskaya mikroangiopatiya u onkologicheskih bol'nyh]. Vestnik RAMN. 2019;74(5):323-32. (In Russ.). https://doi.org/10.15690/vramn1204.Deford C.C., Reese J.A., Schwartz L.H. et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013;122(12):2023-9. https://doi.org/10.1182/blood-2013-04-496752.Deford C.C., Reese J.A., Schwartz L.H. et al. Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood. 2013;122(12):2023-9. https://doi.org/10.1182/blood-2013-04-496752.Falter T., Boschen S., Schepers M. et al. Influence of personality, resilience and life conditions on depression and anxiety in 104 patients having survived acute autoimmune thrombotic thrombocytopenic purpura. J Clin Med. 2021;10(2):365. https://doi.org/0.3390/jcm10020365.Falter T., Boschen S., Schepers M. et al. Influence of personality, resilience and life conditions on depression and anxiety in 104 patients having survived acute autoimmune thrombotic thrombocytopenic purpura. J Clin Med. 2021;10(2):365. https://doi.org/0.3390/jcm10020365.Riva S., Mancini I., Maino A. et al. Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2020;105(7):1957-62. https://doi.org/10.3324/haematol.2019.22642.Riva S., Mancini I., Maino A. et al. Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura. Haematologica. 2020;105(7):1957-62. https://doi.org/10.3324/haematol.2019.22642.Westwood J.P., Scully M. Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase. Ther Adv Hematol. 2022;13:20406207221112216. https://doi.org/10.1177/20406207221112217.Westwood J.P., Scully M. Management of acquired, immune thrombocytopenic purpura (iTTP): beyond the acute phase. Ther Adv Hematol. 2022;13:20406207221112216. https://doi.org/10.1177/20406207221112217.Woods A.I., Paiva J., Dos Santos C. et al. From the discovery of ADAMTS13 to current understanding of its role in health and disease. Semin Thromb Hemost. 2023;49(3):284-94. https://doi.org/10.1055/s-0042-1758059.Woods A.I., Paiva J., Dos Santos C. et al. From the discovery of ADAMTS13 to current understanding of its role in health and disease. Semin Thromb Hemost. 2023;49(3):284-94. https://doi.org/10.1055/s-0042-1758059.Scully M., Antun A., Cataland S.R. et al.; cTTP Phase 3 Study Investigators. Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura. N Engl J Med. 2024;390(17):1584-96. https://doi.org/10.1056/NEJMoa2314793.Scully M., Antun A., Cataland S.R. et al.; cTTP Phase 3 Study Investigators. Recombinant ADAMTS13 in congenital thrombotic thrombocytopenic purpura. N Engl J Med. 2024;390(17):1584-96. https://doi.org/10.1056/NEJMoa2314793.Asmis L.M., Serra A., Krafft A. et al. Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura. N Engl J Med. 2022;387(25):2356-61. https://doi.org/10.1056/NEJMoa2211113.Asmis L.M., Serra A., Krafft A. et al. Recombinant ADAMTS13 for hereditary thrombotic thrombocytopenic purpura. N Engl J Med. 2022;387(25):2356-61. https://doi.org/10.1056/NEJMoa2211113.Bendapudi P.K., Foy B.H., Mueller S.B. et al. Recombinant ADAMTS13 for immune thrombotic thrombocytopenic purpura. N Engl J Med. 2024;390(18):1690-8. https://doi.org/10.1056/NEJMoa2402567.Bendapudi P.K., Foy B.H., Mueller S.B. et al. Recombinant ADAMTS13 for immune thrombotic thrombocytopenic purpura. N Engl J Med. 2024;390(18):1690-8. https://doi.org/10.1056/NEJMoa2402567.Dekimpe C., Roose E., Sakai K. et al. Toward gene therapy for congenital thrombotic thrombocytopenic purpura. J Thromb Haemost. 2023;21(5):1090-9. https://doi.org/10.1016/j.jtha.2022.12.018.Dekimpe C., Roose E., Sakai K. et al. Toward gene therapy for congenital thrombotic thrombocytopenic purpura. J Thromb Haemost. 2023;21(5):1090-9. https://doi.org/10.1016/j.jtha.2022.12.018.

The authors declare that there are no conflicts of interest present.